The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
基本信息
- 批准号:8282865
- 负责人:
- 金额:$ 144.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAge of OnsetAgingBaltimoreBrainCardiovascular systemCause of DeathCohort StudiesCollaborationsComputer SimulationDNADataData SetDiseaseDocumentationEnsureEpidemiologyEthnic OriginEthnic groupFunctional disorderFutureGenderGenesGeneticGenetic VariationGenomicsGenotypeGoalsHealthHeartHuman GeneticsIndividualInternationalInvestmentsIschemic StrokeKentuckyMeta-AnalysisNational Institute of Neurological Disorders and StrokeNational Research CouncilNurses&apos Health StudyOutcome StudyPathway interactionsPatientsPhenotypePlayPoliciesPopulationPredispositionPreventionPrevention strategyRaceResearchResearch PersonnelRiskRoleSamplingSiblingsSiteStagingStrokeTestingTrustVariantVascular DiseasesWashingtonWomen&aposs Healthbasecase controlcohortdatabase of Genotypes and Phenotypesdisabilityepidemiology studygenome wide association studygenome-widegeographic differenceinnovationmemberneuroimagingnovelprogramspublic health relevanceracial differencetreatment strategy
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this application is to characterize the genetic basis for stroke susceptibility in order to develop more effective prevention and treatment strategies. Our study will thoroughly test the hypothesis that common variants play a major role in stroke, setting the stage for the future genetic study of this disease. This proposal builds on the innovative collaborative network established by the International Stroke Genetics Consortium (ISGC). For the present proposal, ISGC members from the USA have formed a smaller consortium, which includes the following studies: Baltimore-Washington Young Stroke Study, Siblings with Ischemic Stroke Study, Ischemic Stroke Genetics Study, Greater Cincinnati/Northern Kentucky Stroke Study, Northern Manhattan Study, Genes Affecting Stroke Risk and Outcome Study/Bugher Network Study, Heart and Vascular Health Stroke Study, Reasons for Geographic and Racial Differences in Stroke, Nurses Health Study, and Women's Health Initiative. Our specific aims are to: 1. Assemble ischemic stroke phenotypic data and either high quality DNA samples or genotype data from 10 stroke studies with access to 7,033 cases of ischemic stroke and 23,411 study-specific controls. Phenotype data will be harmonized and new genome-wide genotyping will be performed on an estimated 4,420 cases and 3,277 controls. 2. Test for associations with ischemic stroke, rigorously categorized according to subtypes, within this 10- study consortium. Study-specific analyses will be performed and these results will be combined for a metaanalysis of ischemic stroke and its subtypes, with secondary analyses addressing subpopulations, including race/ethnicity, gender, and age of onset. 3. Replicate and extend associations detected in Aim 2 above by taking advantage of other genome-wide association studies conducted by members of the ISGC, including the Wellcome Trust Case-Control Consortium, the Australian National Research Council Study, and the Cohorts for Heart and Aging Research in Genomic Epidemiology.
PUBLIC HEALTH RELEVANCE: Stroke, defined as acute vascular disease of the brain, is the third leading cause of death and the leading cause of major disability. The long-range goal of our research is to characterize the genetic basis for stroke susceptibility in order to develop the effective prevention and treatment strategies that are desperately needed.
描述(由申请人提供):本申请的长期目标是表征卒中易感性的遗传基础,以开发更有效的预防和治疗策略。我们的研究将彻底验证常见变异在中风中起主要作用的假设,为未来这种疾病的遗传研究奠定基础。该提案建立在国际中风遗传学联盟(ISGC)建立的创新合作网络的基础上。对于本提案,来自美国的ISGC成员组成了一个较小的财团,其中包括以下研究:巴尔的摩-华盛顿青年卒中研究,缺血性卒中研究,缺血性卒中遗传学研究,大辛辛那提/北方肯塔基州卒中研究,北方曼哈顿研究,影响卒中风险和结局的基因研究/Bugher网络研究,心脏和血管健康卒中研究,中风的地理和种族差异的原因,护士健康研究和妇女健康倡议。我们的具体目标是:1.收集缺血性中风表型数据以及来自10项中风研究的高质量DNA样本或基因型数据,这些研究涉及7,033例缺血性中风病例和23,411例研究特定对照。表型数据将得到统一,并将对估计的4,420例病例和3,277例对照进行新的全基因组基因分型。2.在这个10项研究的联盟中,根据亚型严格分类,测试与缺血性卒中的相关性。将进行研究特定分析,并将这些结果合并用于缺血性卒中及其亚型的荟萃分析,次要分析涉及亚群,包括人种/种族、性别和发病年龄。3.通过利用ISGC成员进行的其他全基因组关联研究,包括Wellcome Trust病例对照联合会、澳大利亚国家研究理事会研究和基因组流行病学心脏和衰老研究队列,复制和扩展上述目标2中检测到的关联。
公共卫生相关性:中风,定义为急性脑血管疾病,是第三大死亡原因和主要残疾的主要原因。我们研究的长期目标是描述中风易感性的遗传基础,以制定迫切需要的有效预防和治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Howard其他文献
George Howard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Howard', 18)}}的其他基金
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10688017 - 财政年份:2021
- 资助金额:
$ 144.03万 - 项目类别:
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10294280 - 财政年份:2021
- 资助金额:
$ 144.03万 - 项目类别:
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
CREST-2随机临床试验参与者的长期观察延伸
- 批准号:
10473895 - 财政年份:2021
- 资助金额:
$ 144.03万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
10298040 - 财政年份:2014
- 资助金额:
$ 144.03万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
9898483 - 财政年份:2014
- 资助金额:
$ 144.03万 - 项目类别:
CREST-2 Statistical and Data Coordinating Center - SDCC
CREST-2 统计和数据协调中心 - SDCC
- 批准号:
8577740 - 财政年份:2014
- 资助金额:
$ 144.03万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
8099667 - 财政年份:2010
- 资助金额:
$ 144.03万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
7848501 - 财政年份:2010
- 资助金额:
$ 144.03万 - 项目类别:
The NINDS International Stroke Genetics Consortium Study
NINDS 国际中风遗传学联盟研究
- 批准号:
8479444 - 财政年份:2010
- 资助金额:
$ 144.03万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 144.03万 - 项目类别:
Research Grant